Trial Profile
Pemetrexed + gemcitabine versus carboplatin + gemcitabine in patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms PAGe
- 07 Jul 2011 Results presented at the 14th World Conference on Lung Cancer.
- 05 Nov 2010 New trial record.